Sees FY24 revenue up 4.5%-5.5%, consensus $7.7B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ZBH:
- Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results
- Is ZBH a Buy, Before Earnings?
- Zimmer Biomet price target raised to $140 from $134 at RBC Capital
- Zimmer Biomet downgraded to In Line from Outperform at Evercore ISI
- Zimmer Biomet price target raised to $133 from $115 at Truist